Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Engineering viral genomics and nano-liposomes in microfluidic platforms for patient-specific analysis of SARS-CoV-2 variants.

Theranostics - 1 Jan 2022

Satta Sandro, Shahabipour Fahimeh, Gao Wei, Lentz Steven R, Perlman Stanley, Ashammakhi Nureddin, Hsiai Tzung

Abstract excerpt

New variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are continuing to spread globally, contributing to the persistence of the COVID-19 pandemic. Increasing resources have been focused on developing vaccines and therapeutics that target the Spike glycoprotein of SARS-CoV-2. Recent advances in microfluidics have the potential to recapitulate viral infection in the organ-specific platforms,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neutralizing
Share to Antibodies, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liposomes

Share to Microfluidics

Share to Pandemics

Share to Peptidyl-Dipeptidase A

Share to SARS-CoV-2

Share to Spike Glycoprotein, Coronavirus

Source

Open in PubMed Open full text

Identifiers

PMID: 35832078
DOI: 10.7150/thno.72339
PMCID: PMC9254234

Genes

ACE2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Engineering viral genomics and nano-liposomes in microfluidic platforms for patient-specific analysis of SARS-CoV-2 variants.PMID 35832078Read ↗

A high-throughput microfluidic nano-immunoassay for detecting anti-SARS-CoV-2 antibodies in serum or ultra-low volume dried blood samplesSemantic proximity Read ↗

Development of Nucleocapsid-Specific Monoclonal Antibodies for SARS-CoV-2 and Their ELISA Diagnostics on an Automatic Microfluidic DeviceSemantic proximity Read ↗

Host-Directed Virus-Mimicking Particles Interacting with the ACE2 Receptor Competitively Block Coronavirus SARS-CoV-2 EntrySemantic proximity Read ↗

Microfluidics-enabled fluorescence-activated cell sorting of single pathogen-specific antibody secreting cells for the rapid discovery of monoclonal antibodiesSemantic proximity Read ↗

Integrated antigenic and nucleic acid detection in single virions and virion-infected host-derived extracellular vesiclesSemantic proximity Read ↗

Droplet-based single-cell pairing for high-throughput interaction mapping of antigen-receptor combinations.Semantic proximity Read ↗

Mammalian cells-based platforms for the generation of SARS-CoV-2 virus-like particlesSemantic proximity Read ↗

Rapid differential diagnosis of the B.1.617.2 (delta) variant of SARS-CoV-2 using an automated Cas12a-microfluidic system.Semantic proximity Read ↗

Simultaneous detection of SARS-CoV-2 and influenza A/B viruses on an electromagnetically-driven, integrated microfluidic systemSemantic proximity Read ↗

Clinical sensitivity and specificity of a high-throughput microfluidic nano-immunoassay combined with capillary blood microsampling for the identification of anti-SARS-CoV-2 Spike IgG serostatusSemantic proximity Read ↗

Single cell infection with influenza A virus using drop-based microfluidicsSemantic proximity Read ↗

A Sample-to-Answer COVID-19 Diagnostic Device Based on Immiscible Filtration and CRISPR-Cas12a-Assisted DetectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.